Brain Metastasis Model
Brain Metastasis Model - Related Videos
04:58
Brain Metastasis Mouse Model: A Method to Generate Brain Metastasis Mouse Model by Intracarotid Cancer Cell Injection
0 Views •
2025
This video demonstrates the establishment of a brain metastasis mouse model by intracarotid injection of fluorescently labeled cancer cells. The mouse model can be used to study the effects of novel therapeutics and the underlying physiological mechanisms.
07:43
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
0 Views •
Cited by 32 •
2017
Brain metastasis has become an urgent unmet medical need as its incidence has increased while therapeutic options have remained palliative. Creating experimental animal models of brain metastasis via intracarotid arterial injection of cancer cells facilitates mechanistic studies of the disease biology and evaluation of novel intervention regimens.
07:42
Modelling Brain Metastasis: Standardized Analysis of Metastatic Colonization and Histological Growth Patterns by Stereotactic Intracortical Injection
0 Views •
Cited by 1 •
2026
The stereotactic intracranial injection technique enables precise and localized implantation of tumor cells into the mouse cortex, making it a powerful model for studying metastatic colonization of the brain.
08:49
Models of Bone Metastasis
0 Views •
Cited by 115 •
2012
Animal models are frequently utilized to study cancer metastasis to bone. In this protocol we will describe two common methods of tumor inoculation for bone metastasis studies and briefly describe some of the analyses utilized to monitor and quantify these models.
11:43
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
0 Views •
Cited by 6 •
2016
The ability of metastatic clones to colonize distant sites depends on their proliferation capacity and/or their ability to survive in the host microenvironment without significant proliferation. Here, we present an animal model that allows quantitative visualization of both types of liver colonization by metastatic clones.
FAQs
The blood-brain barrier is a central feature because metastatic cells must interact with this protective interface before establishing growth in brain tissue. Models that examine this interaction can help investigators study tumor cell entry and invasion alongside communication with the surrounding brain microenvironment. These observations clarify how disease progression may occur within the brain.
The brain microenvironment provides the context in which metastatic tumor cells invade, survive, and grow. Including this context allows researchers to examine communication between cancer cells and brain-associated components rather than studying tumor behavior in isolation. That information can reveal mechanisms linked to progression and help identify biological features relevant to treatment development.
These formats provide different experimental settings for examining the same broad disease process. Cultured cells can support focused investigation of tumor behavior, while three-dimensional systems and animal models can represent more complex interactions involving invasion, the blood-brain barrier, and the brain microenvironment. Together, they provide complementary evidence for studying metastatic mechanisms and evaluating interventions.
A study generally begins by selecting an experimental format suited to the question, such as cultured cells, a three-dimensional system, or an animal model. Investigators then examine processes including tumor cell invasion, interaction with the blood-brain barrier, and growth within the brain. Results can subsequently be used to assess biomarkers, treatment response, or resistance.
These models can show how metastatic tumor systems respond to targeted drugs and combination therapies before those treatments reach clinical testing. Researchers can compare treatment effects with patterns of therapeutic resistance and disease progression. Such findings help identify potentially useful treatment strategies and clarify why a therapy may not produce the intended response.
They provide an experimental stage for investigating metastatic mechanisms, biomarkers, drug activity, and resistance before clinical evaluation. By testing targeted drugs or combinations in relevant systems, researchers can gather evidence about treatment response and disease behavior. The resulting knowledge may guide more effective therapies and support the development of patient-specific treatment approaches.